PME

60 drugs in development·39 companies·1 clinical trial

Drug Pipeline by Phase

Approved(21)

Drug	Company
amoxicillin	SUNSET ISLAND GROUP (SUN)
amoxicillin	Aptinyx Inc. (APTX)
amoxicillin	Miromatrix Medical Inc. (MIRO)
atomoxetine	Teva Pharmaceutical Industries Limited (TEVA)
atomoxetine	DR REDDYS LABORATORIES LTD (RDY)
atomoxetine	Aptinyx Inc. (APTX)
azithromycin	SUNSET ISLAND GROUP (SUN)
azithromycin	GT Biopharma, Inc. (GTBP)
cayston	GILEAD SCIENCES, INC. (GILD)
cefepime	Atara Biotherapeutics, Inc. (ATRA)
cefepime	Seagen Inc. (SGEN)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
clarithromycin	SUNSET ISLAND GROUP (SUN)
dificid	Curative Biotechnology Inc (CUBT)
doxycycline	Mylan II B.V. (MYL)
doxycycline hyclate	Prestige Consumer Healthcare Inc. (PBH)
emblaveo	AbbVie Inc. (ABBV)
Follistim AQ	Organon & Co. (OGN)
sivextro	Curative Biotechnology Inc (CUBT)
TZIELD	MACROGENICS INC (MGNX)
zerbaxa	Curative Biotechnology Inc (CUBT)

Phase 3(7)

Drug	Company
1.0mg/kg/day PRAX-562	Praxis Precision Medicines, Inc. (PRAX)
1.5mg/kg/day PRAX-562	Praxis Precision Medicines, Inc. (PRAX)
Bexicaserin (LP352)	Longboard Pharmaceuticals, Inc. (LBPH)
EPX-100	Harmony Biosciences Holdings, Inc. (HRMY)
LP352	Longboard Pharmaceuticals, Inc. (LBPH)
LP352, bexicaserin	Longboard Pharmaceuticals, Inc. (LBPH)
Relutrigine	Praxis Precision Medicines, Inc. (PRAX)

Phase 2(9)

Drug	Company
ABI-H2158 (2158)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
BDTX-1535	Black Diamond Therapeutics, Inc. (BDTX)
Elraglusib Oral Tablet	ACTUATE THERAPEUTICS, INC. (ACTU)
Express Genes	Twist Bioscience Corp (TWST)
INS1148	INSMED Inc (INSM)
Mivavotinib (CB-659, formerly TAK-659)	Calithera Biosciences, Inc. (CALA)
nbi-921352	Xenon Pharmaceuticals Inc. (XENE)
nbi-921352	NEUROCRINE BIOSCIENCES INC (NBIX)
tnx-4800	Tonix Pharmaceuticals Holding Corp. (TNXP)

Phase 1(4)

Drug	Company
ABI-H3733 (3733)	ASSEMBLY BIOSCIENCES, INC. (ASMB)
ANPA-0073	Structure Therapeutics Inc. (GPCR)
EO-3021 (also known as SYSA1801 or CPO102)	Elevation Oncology, Inc. (ELEV)
IMC-T119C (PRAME-A24)	Immunocore Holdings plc (IMCR)

Preclinical(3)

Drug	Company
AR-300	Ampio Pharmaceuticals, Inc. (AMPE)
EPX-200	Harmony Biosciences Holdings, Inc. (HRMY)
pax-102	Kuvatris Therapeutics, Inc. (PXMD)

Unknown(14)

Drug	Company
Ampion®	Ampio Pharmaceuticals, Inc. (AMPE)
Five prioritized antibody leads	Twist Bioscience Corp (TWST)
IgG protein offering	Twist Bioscience Corp (TWST)
IgG Proteins	Twist Bioscience Corp (TWST)
iPScelz™ (iPSC program)	CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ)
KRM Chromatography Systems	REPLIGEN CORP (RGEN)
lunre+camo	Repare Therapeutics Inc. (RPTX)
OPUS Pre-Packed Columns	REPLIGEN CORP (RGEN)
Serious Seeds proprietary strains / Collaborative Products	Target Group Inc. (CBDY)
SJ02	Organon & Co. (OGN)
SoloVPE	REPLIGEN CORP (RGEN)
Synthetic Controls	Twist Bioscience Corp (TWST)
Synthetic RNA (SRNA) technology platform	Ainos Inc. (AIMD)
Vebicorvir (VBR)	ASSEMBLY BIOSCIENCES, INC. (ASMB)

Phase 1/Phase 2(2)

Drug	Company
CLN-619	Cullinan Therapeutics, Inc. (CGEM)
gene therapy	Gene Biotherapeutics, Inc. (CRXM)

BioSniper tracks 60 drugs in development for PME across 39 companies.

There are 1 clinical trial targeting PME tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.